Asthma is a respiratory disease related to chronic inflammation of the bronchi characterized by obstruction of the airways leading to the lungs.
- Chest tightness
There are more than 4 million asthmatics in France (6.7% of the population and 9% of children). It is the leading chronic disease of children and causes 1000 deaths per year in the under 65s. (Source Asthme et allergies association).
The Spirolyser® Q13® spirometer is a tool for the diagnosis and management of asthmatics. If you have asthma and have never had a spirometry test, talk to your doctor.
Chronic Obstructive Pulmonary Disease (COPD) affects more than 3.5 million people (7.5% of the adult population have COPD). 16,000 patients die from it annually, i.e. 3% of deaths in France.
Diagnosis can be made by spirometry demonstrating the “obstructive ventilatory disorder”.
Smoking is by far the main risk factor in developed countries: 30% of smokers who exceed 1 packet/day for 20 years will develop COPD, i.e. 2,500,000 cases in France.
- Chronic cough upon waking, “smoker’s cough”
- Shortness of breath on effort, attributed to a lack of fitness. (Source : Pneumocourlancy).
- The Spirolyser® Q13® helps to identify COPD-related disorders.